UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Australia OKs Daewoong's P1 trial for idiopathic pulmonary fibrosis treatment
by Lee Han-soo
2019-08-22 14:36
K-Hospital Fair 2019 opens 3-day show in Seoul
by Lee Han-soo
2019-08-21 23:36
Chong Kun Dang invests ₩5 billion in Biorchestra
by Lee Han-soo
2019-08-21 16:42
‘GSK’s hair loss treatment Avodart works well for Koreans’
by Lee Han-soo
2019-08-20 17:46
JW’s European partner launches 3rd-gen parenteral nutrition solution in EU
by Lee Han-soo
2019-08-20 17:46
라인
Genexine, Toolgen merger deal falls through
by Lee Han-soo
2019-08-20 11:21
Combo drugs: latest trend in local pharmaceuticals
by Lee Hye-seon
2019-08-19 16:02
Boryung to sell antihypertensive drugs in Mexico
by Lee Han-soo
2019-08-19 14:31
Rivalry among PARP inhibitors intense in ovarian cancer treatment
by Kim Yun-mi
2019-08-19 14:00
Local drugmakers speed up NASH drug development
by Lee Hye-seon
2019-08-16 13:52
라인
Theragen Etex turns profitable after marking record Q2 sales
by Lee Han-soo
2019-08-14 17:22
AstraZeneca wins expanded indication for type 2 diabetes treatment Forxiga
by Lee Han-soo
2019-08-14 16:17
Korean firms eyeing on growing orphan drug market
by Jeong Sae-im
2019-08-14 14:48
Huons Global hits record-high 1H sales
by Lee Han-soo
2019-08-14 14:46
Court dismisses Kolon's petition to suspend government's step on Invossa
by Lee Han-soo
2019-08-14 11:57
라인
Hugel posts ₩50.3 billion in Q2 sales
by Lee Han-soo
2019-08-13 18:13
Last trial OKed for Eylea to prevent blindness in premature infants
by Lee Hye-seon
2019-08-13 12:42
Daewoong's idiopathic pulmonary fibrosis treatment wins orphan drug status
by Lee Han-soo
2019-08-13 11:12
Roche wins additional indication for breast cancer treatment Kadcyla
by Lee Han-soo
2019-08-12 15:17
Yuhan can continue testing lung cancer drug Lazertinib
by Lee Hye-seon
2019-08-12 12:58
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top